A current study from Münster shows that proven antidepressants could help with Covid 19 diseases. You can find out more about this form of treatment here.
Opinions differ when it comes to antidepressants: They are controversial, but help where it is no longer possible without them. But why are psychotropic drugs now associated with Covid-19?
Many people suffer from coronavirus disease of psychological concomitant symptoms that range from sleep disorders to depression and dementia can.
A research team from the Westfälische Wilhelms-Universität Münster found out in a preliminary study that the antidepressant Prozac significantly inhibits the spread of SARS-CoV-2 viruses in the body and thus could prevent a third corona wave.
“Folk drug” does not only help against depression
Prozac is an antidepressant used since 1988, which is actually used for depression to lower serotonin levels. This psychotropic drug is also known as a folk drug because it has been used for 30 years, like the Southgerman newspaper writes.
Ursula Rescher’s team of scientists has now found out that the drug also inhibits the spread of Covid-19 pathogens and can thus alleviate a severe course of the disease without damaging the cells or tissue.
Fluvoxamine follows suit
Scientists at Washington University conducted a similar study with the antidepressant Fluvoxamin by. They concluded that the antidepressant can prevent Covid-19 diseases from getting worse.
Also other active ingredients that can influence cell growth and cell death, such as drugs Amidaron and Imipramin, could show promising effects.
Further studies needed
The study from Münster has so far only been carried out on cell cultures in the laboratory and the figures from the American study are not meaningful due to the small number of test persons.
To the effectiveness of drugs like Fluvoxamin and Prozac To confirm the fight against the coronavirus, further studies are initially required.
A ray of hope in the fight against Corona
In view of the current situation and the coronavirus, which is spreading constantly and apparently unhindered, this research progress is clearly a ray of hope.
Because in addition to an effective vaccine, we still lack a means that can be used to treat patients who are already suffering from Covid-19. The main advantage of the examined antidepressants is that they have been on the market for a long time and are available everywhere.